Samples for study ST003286
Species: Homo sapiens (Factor headings shown in green)mb_sample_id | Subject name | Sample name | Sample source | Cell line | Culture Type | Immune checkpoint inhibitor | Sample_Data:RAW_FILE_NAME(Subject) |
---|---|---|---|---|---|---|---|
SA356221 | - | CD_A549_3_1_IPI3_rep1 | Non-small cell lung cancer cells | A549 | Direct Co-culture | Ipilimumab | CD_A549_3_1_IPI3_rep1 |
SA356222 | - | CD_A549_3_1_IPI3_rep2 | Non-small cell lung cancer cells | A549 | Direct Co-culture | Ipilimumab | CD_A549_3_1_IPI3_rep2 |
SA356220 | - | CD_A549_3_1_IPI3_rep3 | Non-small cell lung cancer cells | A549 | Direct Co-culture | Ipilimumab | CD_A549_3_1_IPI3_rep3 |
SA356225 | - | CD_A549_3_1_NIV3_rep1 | Non-small cell lung cancer cells | A549 | Direct Co-culture | Nivolumab | CD_A549_3_1_NIV3_rep1 |
SA356223 | - | CD_A549_3_1_NIV3_rep3 | Non-small cell lung cancer cells | A549 | Direct Co-culture | Nivolumab | CD_A549_3_1_NIV3_rep3 |
SA356224 | - | CD_A549_TW_NIV2_rep2 | Non-small cell lung cancer cells | A549 | Direct Co-culture | Nivolumab | CD_A549_TW_NIV2_rep2 |
SA356228 | - | CD_A549_3_1_CTL3_rep1 | Non-small cell lung cancer cells | A549 | Direct Co-culture | No treatment | CD_A549_3_1_CTL3_rep1 |
SA356226 | - | CD_A549_3_1_CTL3_rep3 | Non-small cell lung cancer cells | A549 | Direct Co-culture | No treatment | CD_A549_3_1_CTL3_rep3 |
SA356227 | - | CD_A549_TW_CTL2_rep2 | Non-small cell lung cancer cells | A549 | Direct Co-culture | No treatment | CD_A549_TW_CTL2_rep2 |
SA356229 | - | CD_A549_TW_IPI3_rep1 | Non-small cell lung cancer cells | A549 | Indirect Co-culture | Ipilimumab | CD_A549_TW_IPI3_rep1 |
SA356230 | - | CD_A549_TW_IPI3_rep2 | Non-small cell lung cancer cells | A549 | Indirect Co-culture | Ipilimumab | CD_A549_TW_IPI3_rep2 |
SA356231 | - | CD_A549_TW_IPI3_rep3 | Non-small cell lung cancer cells | A549 | Indirect Co-culture | Ipilimumab | CD_A549_TW_IPI3_rep3 |
SA356232 | - | CD_A549_NIV2_rep2 | Non-small cell lung cancer cells | A549 | Indirect Co-culture | Nivolumab | CD_A549_NIV2_rep2 |
SA356234 | - | CD_A549_TW_NIV3_rep1 | Non-small cell lung cancer cells | A549 | Indirect Co-culture | Nivolumab | CD_A549_TW_NIV3_rep1 |
SA356233 | - | CD_A549_TW_NIV3_rep3 | Non-small cell lung cancer cells | A549 | Indirect Co-culture | Nivolumab | CD_A549_TW_NIV3_rep3 |
SA356236 | - | CD_A549_CTL2_rep2 | Non-small cell lung cancer cells | A549 | Indirect Co-culture | No treatment | CD_A549_CTL2_rep2 |
SA356237 | - | CD_A549_TW_CTL3_rep1 | Non-small cell lung cancer cells | A549 | Indirect Co-culture | No treatment | CD_A549_TW_CTL3_rep1 |
SA356235 | - | CD_A549_TW_CTL3_rep3 | Non-small cell lung cancer cells | A549 | Indirect Co-culture | No treatment | CD_A549_TW_CTL3_rep3 |
SA356240 | - | CD_A549_IPI3_rep1 | Non-small cell lung cancer cells | A549 | Monoculture | Ipilimumab | CD_A549_IPI3_rep1 |
SA356239 | - | CD_A549_IPI3_rep2 | Non-small cell lung cancer cells | A549 | Monoculture | Ipilimumab | CD_A549_IPI3_rep2 |
SA356238 | - | CD_A549_IPI3_rep3 | Non-small cell lung cancer cells | A549 | Monoculture | Ipilimumab | CD_A549_IPI3_rep3 |
SA356243 | - | CD_A549_3_1_NIV2_rep2 | Non-small cell lung cancer cells | A549 | Monoculture | Nivolumab | CD_A549_3_1_NIV2_rep2 |
SA356242 | - | CD_A549_NIV3_rep1 | Non-small cell lung cancer cells | A549 | Monoculture | Nivolumab | CD_A549_NIV3_rep1 |
SA356241 | - | CD_A549_NIV3_rep3 | Non-small cell lung cancer cells | A549 | Monoculture | Nivolumab | CD_A549_NIV3_rep3 |
SA356244 | - | CD_A549_3_1_CTL2_rep2 | Non-small cell lung cancer cells | A549 | Monoculture | No treatment | CD_A549_3_1_CTL2_rep2 |
SA356245 | - | CD_A549_CTL3_rep1 | Non-small cell lung cancer cells | A549 | Monoculture | No treatment | CD_A549_CTL3_rep1 |
SA356246 | - | CD_A549_CTL3_rep3 | Non-small cell lung cancer cells | A549 | Monoculture | No treatment | CD_A549_CTL3_rep3 |
SA356249 | - | CD_H292_TW_IPI1_rep1 | Non-small cell lung cancer cells | H292 | Direct Co-culture | Ipilimumab | CD_H292_TW_IPI1_rep1 |
SA356247 | - | CD_H292_TW_IPI1_rep2 | Non-small cell lung cancer cells | H292 | Direct Co-culture | Ipilimumab | CD_H292_TW_IPI1_rep2 |
SA356248 | - | CD_H292_TW_IPI1_rep3 | Non-small cell lung cancer cells | H292 | Direct Co-culture | Ipilimumab | CD_H292_TW_IPI1_rep3 |
SA356252 | - | CD_H292_TW_NIV1_rep1 | Non-small cell lung cancer cells | H292 | Direct Co-culture | Nivolumab | CD_H292_TW_NIV1_rep1 |
SA356251 | - | CD_H292_TW_NIV1_rep2 | Non-small cell lung cancer cells | H292 | Direct Co-culture | Nivolumab | CD_H292_TW_NIV1_rep2 |
SA356250 | - | CD_H292_TW_NIV1_rep3 | Non-small cell lung cancer cells | H292 | Direct Co-culture | Nivolumab | CD_H292_TW_NIV1_rep3 |
SA356255 | - | CD_H292_TW_CTL1_rep1 | Non-small cell lung cancer cells | H292 | Direct Co-culture | No treatment | CD_H292_TW_CTL1_rep1 |
SA356254 | - | CD_H292_TW_CTL1_rep2 | Non-small cell lung cancer cells | H292 | Direct Co-culture | No treatment | CD_H292_TW_CTL1_rep2 |
SA356253 | - | CD_H292_TW_CTL1_rep3 | Non-small cell lung cancer cells | H292 | Direct Co-culture | No treatment | CD_H292_TW_CTL1_rep3 |
SA356258 | - | CD_H292_IPI1_rep1 | Non-small cell lung cancer cells | H292 | Indirect Co-culture | Ipilimumab | CD_H292_IPI1_rep1 |
SA356257 | - | CD_H292_IPI1_rep2 | Non-small cell lung cancer cells | H292 | Indirect Co-culture | Ipilimumab | CD_H292_IPI1_rep2 |
SA356256 | - | CD_H292_IPI1_rep3 | Non-small cell lung cancer cells | H292 | Indirect Co-culture | Ipilimumab | CD_H292_IPI1_rep3 |
SA356260 | - | CD_H292_NIV1_rep1 | Non-small cell lung cancer cells | H292 | Indirect Co-culture | Nivolumab | CD_H292_NIV1_rep1 |
SA356261 | - | CD_H292_NIV1_rep2 | Non-small cell lung cancer cells | H292 | Indirect Co-culture | Nivolumab | CD_H292_NIV1_rep2 |
SA356259 | - | CD_H292_NIV1_rep3 | Non-small cell lung cancer cells | H292 | Indirect Co-culture | Nivolumab | CD_H292_NIV1_rep3 |
SA356264 | - | CD_H292_CTL1_rep1 | Non-small cell lung cancer cells | H292 | Indirect Co-culture | No treatment | CD_H292_CTL1_rep1 |
SA356263 | - | CD_H292_CTL1_rep2 | Non-small cell lung cancer cells | H292 | Indirect Co-culture | No treatment | CD_H292_CTL1_rep2 |
SA356262 | - | CD_H292_CTL1_rep3 | Non-small cell lung cancer cells | H292 | Indirect Co-culture | No treatment | CD_H292_CTL1_rep3 |
SA356267 | - | CD_H292_3_1_IPI1_rep1 | Non-small cell lung cancer cells | H292 | Monoculture | Ipilimumab | CD_H292_3_1_IPI1_rep1 |
SA356266 | - | CD_H292_3_1_IPI1_rep2 | Non-small cell lung cancer cells | H292 | Monoculture | Ipilimumab | CD_H292_3_1_IPI1_rep2 |
SA356265 | - | CD_H292_3_1_IPI1_rep3 | Non-small cell lung cancer cells | H292 | Monoculture | Ipilimumab | CD_H292_3_1_IPI1_rep3 |
SA356270 | - | CD_H292_3_1_NIV1_rep1 | Non-small cell lung cancer cells | H292 | Monoculture | Nivolumab | CD_H292_3_1_NIV1_rep1 |
SA356269 | - | CD_H292_3_1_NIV1_rep2 | Non-small cell lung cancer cells | H292 | Monoculture | Nivolumab | CD_H292_3_1_NIV1_rep2 |
SA356268 | - | CD_H292_3_1_NIV1_rep3 | Non-small cell lung cancer cells | H292 | Monoculture | Nivolumab | CD_H292_3_1_NIV1_rep3 |
SA356272 | - | CD_H292_3_1_CTL1_rep1 | Non-small cell lung cancer cells | H292 | Monoculture | No treatment | CD_H292_3_1_CTL1_rep1 |
SA356271 | - | CD_H292_3_1_CTL1_rep2 | Non-small cell lung cancer cells | H292 | Monoculture | No treatment | CD_H292_3_1_CTL1_rep2 |
SA356273 | - | CD_H292_3_1_CTL1_rep3 | Non-small cell lung cancer cells | H292 | Monoculture | No treatment | CD_H292_3_1_CTL1_rep3 |
SA356276 | - | CD_PC9_3_1_IPI1_rep1 | Non-small cell lung cancer cells | PC-9 | Direct Co-culture | Ipilimumab | CD_PC9_3_1_IPI1_rep1 |
SA356275 | - | CD_PC9_3_1_IPI1_rep2 | Non-small cell lung cancer cells | PC-9 | Direct Co-culture | Ipilimumab | CD_PC9_3_1_IPI1_rep2 |
SA356274 | - | CD_PC9_3_1_IPI1_rep3 | Non-small cell lung cancer cells | PC-9 | Direct Co-culture | Ipilimumab | CD_PC9_3_1_IPI1_rep3 |
SA356279 | - | CD_PC9_NIV1_rep1 | Non-small cell lung cancer cells | PC-9 | Direct Co-culture | Nivolumab | CD_PC9_NIV1_rep1 |
SA356278 | - | CD_PC9_NIV1_rep2 | Non-small cell lung cancer cells | PC-9 | Direct Co-culture | Nivolumab | CD_PC9_NIV1_rep2 |
SA356277 | - | CD_PC9_NIV1_rep3 | Non-small cell lung cancer cells | PC-9 | Direct Co-culture | Nivolumab | CD_PC9_NIV1_rep3 |
SA356282 | - | CD_PC9_CTL1_rep1 | Non-small cell lung cancer cells | PC-9 | Direct Co-culture | No treatment | CD_PC9_CTL1_rep1 |
SA356281 | - | CD_PC9_CTL1_rep2 | Non-small cell lung cancer cells | PC-9 | Direct Co-culture | No treatment | CD_PC9_CTL1_rep2 |
SA356280 | - | CD_PC9_CTL1_rep3 | Non-small cell lung cancer cells | PC-9 | Direct Co-culture | No treatment | CD_PC9_CTL1_rep3 |
SA356283 | - | CD_PC9_TW_IPI1_rep1 | Non-small cell lung cancer cells | PC-9 | Indirect Co-culture | Ipilimumab | CD_PC9_TW_IPI1_rep1 |
SA356285 | - | CD_PC9_TW_IPI1_rep2 | Non-small cell lung cancer cells | PC-9 | Indirect Co-culture | Ipilimumab | CD_PC9_TW_IPI1_rep2 |
SA356284 | - | CD_PC9_TW_IPI1_rep3 | Non-small cell lung cancer cells | PC-9 | Indirect Co-culture | Ipilimumab | CD_PC9_TW_IPI1_rep3 |
SA356288 | - | CD_PC9_TW_NIV1_rep1 | Non-small cell lung cancer cells | PC-9 | Indirect Co-culture | Nivolumab | CD_PC9_TW_NIV1_rep1 |
SA356287 | - | CD_PC9_TW_NIV1_rep2 | Non-small cell lung cancer cells | PC-9 | Indirect Co-culture | Nivolumab | CD_PC9_TW_NIV1_rep2 |
SA356286 | - | CD_PC9_TW_NIV1_rep3 | Non-small cell lung cancer cells | PC-9 | Indirect Co-culture | Nivolumab | CD_PC9_TW_NIV1_rep3 |
SA356291 | - | CD_PC9_TW_CTL1_rep1 | Non-small cell lung cancer cells | PC-9 | Indirect Co-culture | No treatment | CD_PC9_TW_CTL1_rep1 |
SA356290 | - | CD_PC9_TW_CTL3_rep | Non-small cell lung cancer cells | PC-9 | Indirect Co-culture | No treatment | CD_PC9_TW_CTL3_rep |
SA356289 | - | CD_PC9_TW_CTL3_rep3 | Non-small cell lung cancer cells | PC-9 | Indirect Co-culture | No treatment | CD_PC9_TW_CTL3_rep3 |
SA356294 | - | CD_PC9_IPI3_rep1 | Non-small cell lung cancer cells | PC-9 | Monoculture | Ipilimumab | CD_PC9_IPI3_rep1 |
SA356293 | - | CD_PC9_IPI3_rep2 | Non-small cell lung cancer cells | PC-9 | Monoculture | Ipilimumab | CD_PC9_IPI3_rep2 |
SA356292 | - | CD_PC9_IPI3_rep3 | Non-small cell lung cancer cells | PC-9 | Monoculture | Ipilimumab | CD_PC9_IPI3_rep3 |
SA356297 | - | CD_PC9_3_1_NIV1_rep1 | Non-small cell lung cancer cells | PC-9 | Monoculture | Nivolumab | CD_PC9_3_1_NIV1_rep1 |
SA356296 | - | CD_PC9_3_1_NIV1_rep2 | Non-small cell lung cancer cells | PC-9 | Monoculture | Nivolumab | CD_PC9_3_1_NIV1_rep2 |
SA356295 | - | CD_PC9_3_1_NIV1_rep3 | Non-small cell lung cancer cells | PC-9 | Monoculture | Nivolumab | CD_PC9_3_1_NIV1_rep3 |
SA356300 | - | CD_PC9_3_1_CTL1_rep1 | Non-small cell lung cancer cells | PC-9 | Monoculture | No treatment | CD_PC9_3_1_CTL1_rep1 |
SA356298 | - | CD_PC9_3_1_CTL1_rep2 | Non-small cell lung cancer cells | PC-9 | Monoculture | No treatment | CD_PC9_3_1_CTL1_rep2 |
SA356299 | - | CD_PC9_3_1_CTL1_rep3 | Non-small cell lung cancer cells | PC-9 | Monoculture | No treatment | CD_PC9_3_1_CTL1_rep3 |